Market Overview:
The global allergy immunotherapies market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of allergic diseases, increasing awareness about allergy immunotherapy, and technological advancements in the field of allergy immunotherapy. The subcutaneous immunotherapy segment is expected to dominate the global allergy immunotherapies market during the forecast period. This segment is expected to grow at a CAGR of 7.8% from 2018 to 2030.
 Industry Outlook.svg)
Product Definition:
Allergy immunotherapy, also known as desensitization or therapy, is a medical treatment for allergies. It involves exposing people to small amounts of allergens so that their immune system becomes less sensitive to them. This can be done with injections (allergy shots), tablets, or drops under the tongue.
Subcutaneous Immunotherapy:
Subcutaneous immunotherapy (SCIT) is a form of allergy immunotherapy, which involves the injection of allergens under the skin. This treatment is usually done in patients who are not able to receive vaccines or medicines for treating allergies.
According to National Institute of Health (NIH), subcutaneous immunotherapy has been used on a large scale since the early 1970s and has proven effective in both children.
Sublingual Immunotherapy:
Sublingual immunotherapy is a drug delivery method which involves the active ingredient to be administered in the form of a tablet or liquid, and then absorbed by the body through mouth. The drug is then transported to blood vessels in the lungs where it triggers an immune response, leading to allergy symptoms reduction.
Application Insights:
The allergic rhinitis segment dominated the global market in 2017. The application of subcutaneous immunotherapy for the treatment of allergic rhinitis is well established and there are several products available in the market. However, due to lack of awareness regarding this therapy among physicians and patients, its adoption is low in some regions such as Asia Pacific.
On the other hand, other applications include food allergy & anaphylaxis which accounts for a smaller share as compared to allergic rhinitis or asthma. This can be attributed to underdiagnosis and undertreatment of these conditions that have resulted in high unmet needs according to various studies conducted over past few years. For instance, according to a study published by Allergy UK on October 2016, approximately 40%of U.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, such as Merck & Co., Inc.; F. Hoffmann-La Roche AG; and Allergan PLC in this region. Moreover, increasing prevalence of allergic disorders is also one of the major factors responsible for regional growth. According to an article published by NCBI, around 6 million people suffer from food allergy in U.S., out of which only 0-25% have been diagnosed [ ]. Thus, a large unmet clinical need exists for allergen immunotherapy treatment among patients with suspected food allergies [].
Asia Pacific is expected to witness lucrative growth over the forecast period owing to rising disposable income and improving healthcare infrastructure especially in emerging countries like China and India ( ). Furthermore, growing awareness about various allergy treatments will propel market demand during the forecast period ( ).
Growth Factors:
- Increasing prevalence of allergic diseases: The global prevalence of allergic diseases is increasing at an alarming rate. This is mainly due to the changing lifestyles and environmental factors. Allergy Immunotherapy offers a potential solution to this problem and is expected to grow at a rapid pace in the coming years.
- Growing awareness about Allergy Immunotherapy: There is growing awareness about the benefits of Allergy Immunotherapy among both patients and healthcare professionals. This is helping to drive demand for these therapies worldwide.
- Technological advancements: The field of allergy immunotherapy is constantly evolving with new technologies being developed all the time. This has helped to improve the efficacy and safety profile of these therapies, thus driving their growth globally.
Scope Of The Report
Report Attributes
Report Details
Report Title
Allergy Immunotherapies (Allergy Immunotherapy) Market Research Report
By Type
Subcutaneous Immunotherapy, Sublingual Immunotherapy
By Application
Allergic Rhinitis, Allergic Asthma, Other
By Companies
ALK-Abello, Stallergenes Greer, Merck, Allergy Therapeutics, HAL, WOLW Pharma, Holister Stier, Leti
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
243
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Allergy Immunotherapies (Allergy Immunotherapy) Market Report Segments:
The global Allergy Immunotherapies (Allergy Immunotherapy) market is segmented on the basis of:
Types
Subcutaneous Immunotherapy, Sublingual Immunotherapy
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Allergic Rhinitis, Allergic Asthma, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- ALK-Abello
- Stallergenes Greer
- Merck
- Allergy Therapeutics
- HAL
- WOLW Pharma
- Holister Stier
- Leti
 Market Overview.svg)
Highlights of The Allergy Immunotherapies (Allergy Immunotherapy) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Subcutaneous Immunotherapy
- Sublingual Immunotherapy
- By Application:
- Allergic Rhinitis
- Allergic Asthma
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Allergy Immunotherapies (Allergy Immunotherapy) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Allergy immunotherapy is a type of treatment that helps people with allergies control their symptoms. Allergy immunotherapy involves using medications to help the body’s immune system fight allergens. This can help reduce the number and severity of allergy symptoms.
Some of the key players operating in the allergy immunotherapies (allergy immunotherapy) market are ALK-Abello, Stallergenes Greer, Merck, Allergy Therapeutics, HAL, WOLW Pharma, Holister Stier, Leti.
The allergy immunotherapies (allergy immunotherapy) market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Allergy Immunotherapies (Allergy Immunotherapy) Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Allergy Immunotherapies (Allergy Immunotherapy) Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Allergy Immunotherapies (Allergy Immunotherapy) Market - Supply Chain
4.5. Global Allergy Immunotherapies (Allergy Immunotherapy) Market Forecast
4.5.1. Allergy Immunotherapies (Allergy Immunotherapy) Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Allergy Immunotherapies (Allergy Immunotherapy) Market Size (000 Units) and Y-o-Y Growth
4.5.3. Allergy Immunotherapies (Allergy Immunotherapy) Market Absolute $ Opportunity
5. Global Allergy Immunotherapies (Allergy Immunotherapy) Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Allergy Immunotherapies (Allergy Immunotherapy) Market Size and Volume Forecast by Type
5.3.1. Subcutaneous Immunotherapy
5.3.2. Sublingual Immunotherapy
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Allergy Immunotherapies (Allergy Immunotherapy) Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Allergy Immunotherapies (Allergy Immunotherapy) Market Size and Volume Forecast by Application
6.3.1. Allergic Rhinitis
6.3.2. Allergic Asthma
6.3.3. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Allergy Immunotherapies (Allergy Immunotherapy) Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Allergy Immunotherapies (Allergy Immunotherapy) Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Allergy Immunotherapies (Allergy Immunotherapy) Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Allergy Immunotherapies (Allergy Immunotherapy) Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Allergy Immunotherapies (Allergy Immunotherapy) Demand Share Forecast, 2019-2029
9. North America Allergy Immunotherapies (Allergy Immunotherapy) Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Allergy Immunotherapies (Allergy Immunotherapy) Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Allergy Immunotherapies (Allergy Immunotherapy) Market Size and Volume Forecast by Application
9.4.1. Allergic Rhinitis
9.4.2. Allergic Asthma
9.4.3. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Allergy Immunotherapies (Allergy Immunotherapy) Market Size and Volume Forecast by Type
9.7.1. Subcutaneous Immunotherapy
9.7.2. Sublingual Immunotherapy
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Allergy Immunotherapies (Allergy Immunotherapy) Demand Share Forecast, 2019-2029
10. Latin America Allergy Immunotherapies (Allergy Immunotherapy) Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Allergy Immunotherapies (Allergy Immunotherapy) Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Allergy Immunotherapies (Allergy Immunotherapy) Market Size and Volume Forecast by Application
10.4.1. Allergic Rhinitis
10.4.2. Allergic Asthma
10.4.3. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Allergy Immunotherapies (Allergy Immunotherapy) Market Size and Volume Forecast by Type
10.7.1. Subcutaneous Immunotherapy
10.7.2. Sublingual Immunotherapy
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Allergy Immunotherapies (Allergy Immunotherapy) Demand Share Forecast, 2019-2029
11. Europe Allergy Immunotherapies (Allergy Immunotherapy) Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Allergy Immunotherapies (Allergy Immunotherapy) Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Allergy Immunotherapies (Allergy Immunotherapy) Market Size and Volume Forecast by Application
11.4.1. Allergic Rhinitis
11.4.2. Allergic Asthma
11.4.3. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Allergy Immunotherapie (Allergy Immunotherapy) Market Size and Volume Forecast by Type
11.7.1. Subcutaneous Immunotherapy
11.7.2. Sublingual Immunotherapy
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Allergy Immunotherapies (Allergy Immunotherapy) Demand Share, 2019-2029
12. Asia Pacific Allergy Immunotherapies (Allergy Immunotherapy) Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Allergy Immunotherapies (Allergy Immunotherapy) Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Allergy Immunotherapies (Allergy Immunotherapy) Market Size and Volume Forecast by Application
12.4.1. Allergic Rhinitis
12.4.2. Allergic Asthma
12.4.3. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Allergy Immunotherapies (Allergy Immunotherapy) Market Size and Volume Forecast by Type
12.7.1. Subcutaneous Immunotherapy
12.7.2. Sublingual Immunotherapy
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Allergy Immunotherapies (Allergy Immunotherapy) Demand Share, 2019-2029
13. Middle East & Africa Allergy Immunotherapies (Allergy Immunotherapy) Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Allergy Immunotherapies (Allergy Immunotherapy) Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Allergy Immunotherapies (Allergy Immunotherapy) Market Size and Volume Forecast by Application
13.4.1. Allergic Rhinitis
13.4.2. Allergic Asthma
13.4.3. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Allergy Immunotherapies (Allergy Immunotherapy) Market Size and Volume Forecast by Type
13.7.1. Subcutaneous Immunotherapy
13.7.2. Sublingual Immunotherapy
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Allergy Immunotherapies (Allergy Immunotherapy) Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Allergy Immunotherapies (Allergy Immunotherapy) Market: Market Share Analysis
14.2. Allergy Immunotherapies (Allergy Immunotherapy) Distributors and Customers
14.3. Allergy Immunotherapies (Allergy Immunotherapy) Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. ALK-Abello
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Stallergenes Greer
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Merck
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Allergy Therapeutics
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. HAL
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. WOLW Pharma
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Holister Stier
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Leti
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
